Nasal Eradication of Staphylococcus aureus
For nasal eradication of Staphylococcus aureus colonization, use mupirocin 2% nasal ointment twice daily for 5 days, ideally combined with chlorhexidine gluconate body wash (40 mg/mL), particularly before cardiac and orthopedic surgery. 1
Treatment Regimen
The gold standard protocol consists of:
- Mupirocin 2% nasal ointment: Apply twice daily to both nostrils for 5 days
- Chlorhexidine gluconate (CHG) body wash: 40 mg/mL solution used during the same 5-day period
- Timing: Complete the regimen 1-2 weeks before surgery, as close to the operative date as possible 1
This combination approach is superior to mupirocin alone. While mupirocin monotherapy achieves high short-term eradication rates (94% at 72-96 hours) 2, the addition of CHG body wash specifically reduces S. aureus surgical site infections (risk ratio 0.32,95% CI 0.16-0.62) in confirmed carriers 3. The most recent meta-analysis from 2026 confirms that targeted mupirocin-based decolonization, especially when combined with CHG, significantly reduces S. aureus-related surgical site infections (RR 0.67,95% CI 0.49-0.91) 4.
Strength of Evidence by Surgery Type
Strong recommendation (moderate to high certainty):
- Cardiac surgery
- Orthopedic surgery
- These procedures have the strongest evidence base for decolonization benefit 1
Conditional recommendation (low certainty):
- Other surgical procedures including vascular, gastrointestinal, general, oncologic, gynecologic, and neurologic surgeries 1
The rationale is that surgeries involving prosthetic material or immunocompromised patients derive greater benefit due to higher baseline risk of S. aureus surgical site infections.
Universal vs. Targeted Approach
The evidence supports targeted decolonization (screening carriers first, then treating) over universal decolonization (treating everyone regardless of carrier status):
- Targeted decolonization with mupirocin plus CHG demonstrates high-quality evidence for reducing S. aureus infections 3
- Universal mupirocin alone shows little to no difference in infection rates (GRADE: Moderate to Very low) 3
- However, from a health economics perspective, universal decolonization with mupirocin plus CHG is actually cost-saving compared to targeted approaches, preventing 32 vs. 22 infections per 10,000 patients 3
Critical Timing Considerations
If the 5-day course cannot be completed preoperatively:
- Complete the remaining doses postoperatively 1
- For elective surgery, consider postponing the procedure to complete decolonization if feasible and safe 1
- Do not skip decolonization entirely just because timing is suboptimal
Alternative Agents (When Mupirocin is Not Available)
While mupirocin remains the gold standard, alternatives exist but have weaker evidence:
- Povidone-iodine nasal: Promising but requires more clinical trials 5, 6
- Alcohol-based nasal antiseptic: Under investigation 5, 6
- Bacitracin: Inferior efficacy (44% eradication vs. 94% for mupirocin) and increased allergic dermatitis risk—not recommended 6, 2
Important Caveats and Pitfalls
Mupirocin resistance monitoring:
- Increasing mupirocin resistance is an ongoing concern 5, 6, 4
- Institutions should monitor local resistance patterns in colonizing isolates 1
- Short-term use (5 days) minimizes resistance development compared to prolonged courses
Common mistakes to avoid:
- Using mupirocin alone without CHG body wash in surgical patients—the combination is more effective 3, 4
- Completing decolonization too far in advance of surgery—efficacy decreases over time
- Assuming decolonization works for overall surgical site infections—it specifically targets S. aureus infections, not polymicrobial infections 4
Applicability to MRSA vs. MSSA:
- The same decolonization protocol works for both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains 1
- Most studies did not separate these strains, and benefits translate to both 1, 3
Implementation Considerations
Local epidemiology should guide implementation:
- Assess local prevalence of S. aureus colonization and infection rates
- Consider available financial resources
- Maintain adherence to standard infection control measures (hand hygiene, sterile technique) as these remain paramount 1
The evidence does not support routine use of nasal mupirocin for general infection prophylaxis outside the surgical context 7.